The suspension of exports is intended to ensure the supply of the national market and applies to all participants in the supply chain, including manufacturers.
Multiple sclerosis and hyperactivity medications among those banned from export
Wednesday, 15 April 2026RSS
Context & Explainers
Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) is Portugal’s national regulator for medicines and health products that approves drugs, monitors safety and enforces rules on pricing and reimbursement. In 2025 it approved 928 new medicines — 79% were generics, 38 were designated essential and 236 were national products — which affects which medicines are available and how much they cost at pharmacies.
